Patient perspectives on diagnostic uncertainty and novel diagnostic tests in neuro-oncology
Neuro-Oncology Practice · 01.08.2026 · 13 (4) · 733-742
DOI: 10.1093/nop/npag021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Practice, online erschienen am 07.03.2026. Verfasst von Veerle J Ruijters und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht, The Netherlands. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Guided Management of Pseudoprogression in Glioblastoma.
Abstract (Originalsprache)
Background
In the follow-up of glioma patients, differentiating treatment-associated changes from tumor progression on MRI is challenging. In the Netherlands, this diagnostic uncertainty often leads to watchful waiting, delayed treatment, and patient distress. So far, research on new diagnostic tests has primarily focused on accuracy, while patient perspectives remain largely unexplored. This qualitative study aimed to explore glioma patients’ perspectives on diagnostic uncertainty and the implementation of tests aimed at reducing uncertainty.
Methods
Semi-structured interviews were conducted with 10 diffuse glioma patients (31-70 years old; 50% female) treated at UMC Utrecht, the Netherlands. Two independent coders analyzed interview transcripts thematically to identify key themes in patient perspectives.
Results
Four themes were found: (1) Most patients experienced diagnostic uncertainty, which was stressful for themselves and their loved ones. (2) A new test was considered meaningful if it provided early certainty. Patients wanted certainty to guide treatment, and even without therapeutic options, a certain diagnosis could optimize quality of life by living more consciously. (3) All patients wished to participate in decision-making regarding undergoing new tests, with variable preferences regarding the amount of information to be received. (4) Patients expressed the need for continuity of care, honest communication, and immediate disclosure of test results.
Conclusion
Patients value faster certainty from new diagnostic tests, both to guide treatment for improved survival and quality of life and to optimize quality of life when no therapeutic options remain. Integrating this emphasis on quality of life into diagnostic research may stimulate patient-centered test implementation, ultimately improving neuro-oncological care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht, The Netherlands.
- Department of Neurology, UMC Utrecht Brain Center, UMC Utrecht, Utrecht, The Netherlands.
- Julius Center, Department of Bioethics and Health Humanities, UMC Utrecht, Utrecht, The Netherlands.
- Department of Medical Psychology, Amsterdam UMC, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
ORCID-Profile: Nelleke Tolboom, Tatjana Seute, Tom J Snijders
Förderung
- ZonMw
- Guided Management of Pseudoprogression in Glioblastoma
Zitieren
APA
Ruijters, V. J., Bauer, M. M., Tolboom, N., Seute, T., Visser, L. N. C., & Snijders, T. J. (2026). Patient perspectives on diagnostic uncertainty and novel diagnostic tests in neuro-oncology. Neuro-Oncology Practice, 13(4), 733-742. https://doi.org/10.1093/nop/npag021
Vancouver
Ruijters VJ, Bauer MM, Tolboom N, Seute T, Visser LNC, Snijders TJ. Patient perspectives on diagnostic uncertainty and novel diagnostic tests in neuro-oncology. Neuro-Oncology Practice. 2026;13(4):733-742. doi:10.1093/nop/npag021
BibTeX
@article{Ruijters2026,
author = {Ruijters, Veerle J and Bauer, Marloes M and Tolboom, Nelleke and Seute, Tatjana and Visser, Leonie N C and Snijders, Tom J},
title = {Patient perspectives on diagnostic uncertainty and novel diagnostic tests in neuro-oncology},
journal = {Neuro-Oncology Practice},
year = {2026},
volume = {13},
number = {4},
pages = {733--742},
doi = {10.1093/nop/npag021}
}
EUVIMED